Long-term effects of inhaled anticholinergic drug on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary disease

Internal Medicine

Volumn 35, Issue 10, 1996, Pages 772-778

  Teramoto, Shinji ^a   Matsuse, Takeshi ^a   Sudo, Eiichi ^a   Ohga, Eijiro ^a   Katayama, Hirofumi ^a   Suzuki, Masashi ^a   Ouchi, Yasuyoshi ^a   Fukuchi, Yoshinosuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

breathlessness; chronic airflow limitation; exercise testing; oxitropium bromide; pulmonary function test

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; OXITROPIUM BROMIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; EXERCISE TEST; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY;

EID: 0029843436     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.772     Document Type: Article

References (37)

1. Anthonisen NR, Wright EC. IPPB Trial Group. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 133: 814, 1986.
2. Gross NJ. The Lung Health Study: Disappointment and triumph. JAMA 272: 1539, 1994 (editorial; comment).
3. Rennard SI. Combination bronchodilator therapy in COPD. Chest 107: 171S, 1995.
4. Koyama H, Nishimura K, Ikeda A, Izumi T. A comparison of the bronchodilating effects ot oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease. Chest 104: 1743, 1993.
5. Braun SR, McKenzie WN, Copeland C, Knight L, Ellersieck M. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med 149: 544, 1989.
6. Gross NJ. Anticholinergic agents in chronic bronchitis and emphysema. Postgrad Med J 63 Suppl 1: 29, 1987.
7. Tashkin DP, Ashutosh K, Bleecker ER, et al. Comparison of the anti-cholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: a 90-day multi-center study. Am J Med 81: 81, 1986.
8. Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med 311: 421, 1984.
9. Donohue JF. Management of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1: 129, 1995.
10. Furguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 320: 1017, 1993.
11. Karpel JP, Pesin J, Greenberg D, Gentry E. A comparison of the effect of ipratropium bromide and metaproterenol sulfate in acute exacerbation of COPD. Chest 98: 835, 1990.
12. Karpel JP. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD. Chest 99: 871, 1991.
13. 2-agonist and combination therapy on respiratory impedance in COPD. Chest 101: 166, 1992.
14. Hay JG, Stone P, Carter J, Church S, Eyre-Brook A, Pearson MG, Woodcock AA, Calverley PMA. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 5: 659, 1992.
15. Spence DPS, Hay JG, Carter J, Pearson MG, Calverley PMA. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide. Thorax 48: 1145, 1993.
16. Ikeda A, Nishimura K, Koyama H, Sugiura N, Izumi T. Oxitropium bromide improves exercise performance in patients with COPD. Chest 106: 1740, 1994.
17. Koyama H, Nishimura K, Mio T, Ikeda A, Sugiura N, Izumi T. Bronchial responsiveness and acute bronchodilating response in chronic obstructive pulmonary disease and diffuse panbronchiolitis. Thorax 49: 540, 1994.
18. Teramoto S, Fukuchi Y. Improvements in exercise capacity and dyspnea by inhaled anticholinergic drug in elderly patients with chronic obstructive pulmonary disease. Age Ageing 24: 278, 1995.
19. Teramoto S, Fukuchi Y, Orimo H. Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease. Chest 103: 1774, 1993.
20. Baldwin E de F, Coumand A, Richards DW. Pulmonary insufficiency: I. physiologic classification, clinical methods of analysis. Standard values in normal subjects. Medicine 27: 243, 1948.
21. Burrows B, Kasik JE, Niden AH, Barclay WR. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis 84: 789, 1961.
22. Teramoto S, Fukuchi Y, Nagase T, Matsuse T, Orimo H. A comparison of ventilation components between young and elderly men during exercise. J Gerontol A Biol Sci Med Sci 50A: B34, 1995.
23. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14: 377, 1982.
24. Teramoto S, Fukuchi Y, Nagase T, Matsuse T, Shindo G, Orimo H. Quantitative assessment of dyspnea during exercise before and after bullectomy in giant bulla. Chest 102: 1362, 1992.
25. Thurlbeck WM. Chronic airflow obstruction. In Pathology of the lung. Edited by Thurlbeck WM and Churg AM. New York: Thieme Medical Publishers, Inc., 1995, p. 780.
26. Teramoto S, Fukuchi Y. Bullous emphysema. Curr Opin Pumm Med 2: 90, 1996.
27. O'Hara P, Grill J, Rigdon MA, Connett JE, Lauger GA, Johnston JJ, and The Lung Health Study Group. Design and results of the initial intervention program for the Lung Health Study. Prev Med 22: 304, 1993.
28. Rand CS, Wise RA, Nides MA, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 146: 1559, 1992.
29. Friedman M. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease. Am J Med 100: 30S, 1996.
30. 2-agonist in improving dyspnea and exercise limitation in COPD? Chest 108: 730, 1995.
31. Kawakami Y. Current status and research on chronic respiratory failure in Japan. Intern Med 35: 436, 1996.
32. Mahler DA. Breathlessness in chronic obstructive pulmonary disease. in: Respiratory sensation, Adams A, Guz A, Eds., Maecel Dekker, Inc., 1996, p. 231.
33. Mishima M, Oku Y, Muro S, et al. Relationship between dyspnea in daily life and psychophysiologic state in patients with chronic obstructive pulmonary disease during long-term domiciliary oxygen therapy. Intern Med 35:453, 1996.
34. 1: The Lung Health Study. JAMA 272: 1497, 1994.
35. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15 year follow-up study. Am Rev Respir Dis 119; 895, 1979.
36. Kanner RE, Renzetti AD, Stanish WM, Barkman HW, Klauber MR. Predictors of survival in subjects with chronic airflow limitation. Am J Med 74: 249, 1983.
37. Anthonisen NR. Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trial. Am Rev Respir Dis 140: S95, 1989.